Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases - PubMed (original) (raw)
. 2005 Jul 1;280(26):25216-24.
doi: 10.1074/jbc.M503341200. Epub 2005 Apr 29.
Affiliations
- PMID: 15863497
- DOI: 10.1074/jbc.M503341200
Free article
Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases
Jee Young Sung et al. J Biol Chem. 2005.
Free article
Abstract
Although alpha-synuclein is the main structural component of the insoluble filaments that form Lewy bodies in Parkinson disease (PD), its physiological function and exact role in neuronal death remain poorly understood. In the present study, we examined the possible functional relationship between alpha-synuclein and several forms of matrix metalloproteinases (MMPs) in the human dopaminergic neuroblastoma (SK-N-BE) cell line. When SK-N-BE cells were transiently transfected with alpha-synuclein, it was secreted into the extracellular culture media, concomitantly with a significant decrease in cell viability. Also the addition of nitric oxide-generating compounds to the cells caused the secreted alpha-synuclein to be digested, producing a small fragment whose size was similar to that of the fragment generated during the incubation of alpha-synuclein with various MMPs in vitro. Among several forms of MMPs, alpha-synuclein was cleaved most efficiently by MMP-3, and MALDI-TOF mass spectra analysis showed that alpha-synuclein is cleaved from its C-terminal end with at least four cleavage sites within the non-Abeta component of AD amyloid sequence. Compared with the intact form, the protein aggregation of alpha-synuclein was remarkably facilitated in the presence of the proteolytic fragments, and the fragment-induced aggregates showed more toxic effect on cell viability. Moreover, the levels of MMP-3 were also found to be increased significantly in the rat PD brain model produced by the cerebral injection of 6-hydroxydopamine into the substantia nigra. The present study suggests that the extracellularly secreted alpha-synuclein could be processed via the activation of MMP-3 in a selective manner.
Similar articles
- Role of matrix metalloproteinase 3-mediated alpha-synuclein cleavage in dopaminergic cell death.
Choi DH, Kim YJ, Kim YG, Joh TH, Beal MF, Kim YS. Choi DH, et al. J Biol Chem. 2011 Apr 22;286(16):14168-77. doi: 10.1074/jbc.M111.222430. Epub 2011 Feb 17. J Biol Chem. 2011. PMID: 21330369 Free PMC article. - Increased alpha-synuclein aggregation following limited cleavage by certain matrix metalloproteinases.
Levin J, Giese A, Boetzel K, Israel L, Högen T, Nübling G, Kretzschmar H, Lorenzl S. Levin J, et al. Exp Neurol. 2009 Jan;215(1):201-8. doi: 10.1016/j.expneurol.2008.10.010. Epub 2008 Oct 31. Exp Neurol. 2009. PMID: 19022250 - Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease.
Tabner BJ, Turnbull S, El-Agnaf OM, Allsop D. Tabner BJ, et al. Free Radic Biol Med. 2002 Jun 1;32(11):1076-83. doi: 10.1016/s0891-5849(02)00801-8. Free Radic Biol Med. 2002. PMID: 12031892 Review. - Alpha-synuclein and Parkinson's disease.
Lücking CB, Brice A. Lücking CB, et al. Cell Mol Life Sci. 2000 Dec;57(13-14):1894-908. doi: 10.1007/PL00000671. Cell Mol Life Sci. 2000. PMID: 11215516 Free PMC article. Review.
Cited by
- MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson's disease.
Chung YC, Kim YS, Bok E, Yune TY, Maeng S, Jin BK. Chung YC, et al. Mediators Inflamm. 2013;2013:370526. doi: 10.1155/2013/370526. Epub 2013 Jun 19. Mediators Inflamm. 2013. PMID: 23853428 Free PMC article. - Will posttranslational modifications of brain proteins provide novel serological markers for dementias?
Wang Y, Sørensen MG, Zheng Q, Zhang C, Karsdal MA, Henriksen K. Wang Y, et al. Int J Alzheimers Dis. 2012;2012:209409. doi: 10.1155/2012/209409. Epub 2012 Jun 21. Int J Alzheimers Dis. 2012. PMID: 22779024 Free PMC article. - Identification of allosteric fingerprints of alpha-synuclein aggregates in matrix metalloprotease-1 and substrate-specific virtual screening with single molecule insights.
Kamboj S, Harms C, Wright D, Nash A, Kumar L, Klein-Seetharaman J, Sarkar SK. Kamboj S, et al. Sci Rep. 2022 Apr 6;12(1):5764. doi: 10.1038/s41598-022-09866-7. Sci Rep. 2022. PMID: 35388085 Free PMC article. - Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders.
Rivera S, García-González L, Khrestchatisky M, Baranger K. Rivera S, et al. Cell Mol Life Sci. 2019 Aug;76(16):3167-3191. doi: 10.1007/s00018-019-03178-2. Epub 2019 Jun 13. Cell Mol Life Sci. 2019. PMID: 31197405 Free PMC article. Review. - A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies.
Hartlage-Rübsamen M, Bluhm A, Moceri S, Machner L, Köppen J, Schenk M, Hilbrich I, Holzer M, Weidenfeller M, Richter F, Coras R, Serrano GE, Beach TG, Schilling S, von Hörsten S, Xiang W, Schulze A, Roßner S. Hartlage-Rübsamen M, et al. Acta Neuropathol. 2021 Sep;142(3):399-421. doi: 10.1007/s00401-021-02349-5. Epub 2021 Jul 26. Acta Neuropathol. 2021. PMID: 34309760 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous